We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT03207009
Brief Title: A Study Evaluating the Efficacy and Safety of the LentiGlobin® BB305 Drug Product in Participants With Transfusion-Dependent β-Thalassemia

First Submitted : June 29, 2017
First Submitted that Met QC Criteria : June 29, 2017
First Posted : July 2, 2017

Last Update Submitted that Met QC Criteria : February 4, 2022
Last Update Posted : February 21, 2022